Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Fact Sheet   (AUBD)


Potential 33x Opportunity: 3 Next-Generation Defence Stocks


Here is the latest financial fact sheet of AUROBINDO PHARMA. For more details, see the AUROBINDO PHARMA quarterly results and AUROBINDO PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

AUROBINDO PHARMA Price History

Price Rs 592.4
Mkt Cap Rs m 347,110
Vol '000 214.3
P/E X 14.3
P/CF X 9.1
EPS (TTM) Rs 41.4
1 Day % 2.9
No. of shares m 585.94
1 Week % 6.4
1 Month % 9.0
1 Year % -32.6
52 week H/L Rs 887.9/503.4
As on Aug 12, 2022 03:30:00 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

AUROBINDO PHARMA Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
5-Yr Chart
Click to enlarge
AUROBINDO PHARMA EQUITY SHARE DATA
High Rs8098308381,0231,064 
Low Rs504527281333584 
Sales per share (Unadj.) Rs280.4333.9394.2422.8400.3 
Earnings per share (Unadj.) Rs41.340.348.892.045.7 
Diluted earnings per shareRs41.340.348.892.045.7 
Cash flow per share (Unadj.) Rs50.851.765.3110.064.9 
Dividends per share (Unadj.) Rs2.502.503.004.009.00 
Adj. dividends per shareRs2.502.503.004.009.00 
Avg Dividend yield %0.40.40.50.61.1 
Book value per share (Unadj.) Rs199.4237.1287.1374.3419.4 
Adj. book value per shareRs199.3237.1287.1374.3419.4 
Shares outstanding (eoy) m585.91585.89585.94585.94585.94 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x2.32.01.41.62.1 
Avg P/E ratio x15.916.811.57.418.0 
P/CF ratio (eoy) x12.913.18.66.212.7 
Price / Book Value ratio x3.32.91.91.82.0 
Dividend payout %6.16.26.14.319.7 
Avg Mkt Cap Rs m384,634397,541327,877397,398482,799 
No. of employees `000NANANANANA 
Total wages/salary Rs m21,30825,84932,19235,35034,509 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
AUROBINDO PHARMA INCOME DATA
Net Sales Rs m164,262195,636230,985247,746234,555 
Other income Rs m1,0201,5531,9193,8093,226 
Total revenues Rs m165,282197,189232,904251,555237,781 
Gross profit Rs m37,71838,63948,38281,48042,566 
Depreciation Rs m5,5806,6809,66710,55411,265 
Interest Rs m7772,6263,051745486 
Profit before tax Rs m32,38030,88737,58273,99034,040 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m8,1837,2698,99420,0987,256 
Profit after tax Rs m24,19823,61828,58953,89226,784 
Gross profit margin %23.019.820.932.918.1 
Effective tax rate %25.323.523.927.221.3 
Net profit margin %14.712.112.421.811.4 
AUROBINDO PHARMA BALANCE SHEET DATA
Current assets Rs m121,782153,323164,125198,235181,227 
Current liabilities Rs m86,659120,206113,846106,65181,560 
Net working cap to sales %21.416.921.837.042.5 
Current ratio x1.41.31.41.92.2 
Inventory Days Days1515151925 
Debtors Days Days6864685262 
Net fixed assets Rs m87,641109,388123,520135,778155,104 
Share capital Rs m586586586586586 
"Free" reserves Rs m116,218138,321167,661218,713245,174 
Net worth Rs m116,804138,907168,247219,299245,760 
Long term debt Rs m4,5121,80001,6852,492 
Total assets Rs m209,422262,711287,645334,013336,331 
Interest coverage x42.712.813.3100.371.0 
Debt to equity ratio x00000 
Sales to assets ratio x0.80.70.80.70.7 
Return on assets %11.910.011.016.48.1 
Return on equity %20.717.017.024.610.9 
Return on capital %27.323.824.233.813.9 
Exports to sales %49.149.646.453.831.1 
Imports to sales %19.418.815.116.411.9 
Exports (fob) Rs m80,68197,091107,126133,24872,862 
Imports (cif) Rs m31,85336,74134,90240,61527,965 
Fx inflow Rs m80,72797,316107,445133,44777,245 
Fx outflow Rs m34,70040,58938,99144,94631,524 
Net fx Rs m46,02756,72768,45488,50145,721 
AUROBINDO PHARMA CASH FLOW
From Operations Rs m 19,545 16,510 43,813 33,291 50,165 
From Investments Rs m -19,266 -29,026 -15,676 5,987 -32,116 
From Financial Activity Rs m 8,642 19,191 -19,472 -13,649 -29,693 
Net Cashflow Rs m 8,919 6,656 8,712 25,831 -11,674 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 51.8%
Institution 38.0%
Non-Institution 10.2%
Total 100.0%
Free Float 48.2%
Pledged promoter holdings 15.0%
Shareholding as on Jun 2022
 

Company Information

Regd Off Plot No. 2, Maitrivihar, Ameerpet, Hyderabad - 500038
E-mail info@aurobindo.com Web www.aurobindo.com
Tel 040-23736370/23747340 Fax 040-23741080/23746833
Sector PHARMACEUTICALS Group Aurobindo
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor S. R. Batliboi & Assoc.
CHM: K Ragunathan COMP SEC: B Adi Reddy YEAR OF INC: 1986 BSE CODE: 524804 FV (Rs): 1 DIV YIELD (%): 1.5

Read: AUROBINDO PHARMA 2021-22 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   LUPIN    ZYDUS LIFESCIENCES    DR. REDDYS LAB    SUN PHARMA    CIPLA    

Compare AUROBINDO PHARMA With:   LUPIN    ZYDUS LIFESCIENCES    DR. REDDYS LAB    SUN PHARMA    CIPLA    




Today's Market

Sensex Zooms 130 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.